None listed
Conditions
Interventions
Drug, Procedure/Surgery : product name: 5-FU injection 500mg Choongwae
generic name: 5-fluorouracil
measure of capacity: 5-fluorouracil 200mg
Perform endoscopy and inject 5-FU 200 mg 10cc (20 mg/cc)
Sponsors
Kangbuk Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. white blood cell levels are greater than 4×109/L 2. Platelet levels of 100×109/L or higher 3. bilirubin is not more than 2.0g/dL 4. AST/ALT levels are less than three times the normal range 5. creatinine rate of 50mL/min or higher
Exclusion criteria
Exclusion criteria: 1. a history of other cancers besides stomach cancer 2. Patients who disagree with this study 3. A female who is pregnant, may be pregnant, or is lactating 4. A person who has participated in another clinical trial within one month or is expected to participate during the clinical trial period. 5. Patients on Tegapur, Guimerasil and Oterasil potassium complex and patients within 7 days of discontinuation of administration 6. Patient on Soribuddin 7. Patients with a history of severe hypersensitivity to 5-FU 8. Other anti-cancer treatments, post-radiation, bone marrow degradation, or extreme weakness patients 9. Patients with non-malignant tumor diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the size and area of a tumor on an endoscope | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in patient weight and activity based on ECOG;Changes in blood and urine test results;Food intake is available (evaluated in five stages: non-available, water, rice, porridge, and rice) | — |
Countries
Korea, Republic of
Contacts
Public Contactjiae lee
Kangbuk Samsung Medical Center
Outcome results
None listed